Allergy research (CFDA 93.855) in New York 12th District (NY-12)

Reading CFDA 93.855 inside NY-12

CFDA 93.855 and congressional district NY-12 meet here. $901,064,298.03 is the USAspending.gov obligation sum on awards that carry both tags. It is not Allergy And Infectious Diseases Research’s nationwide total, not every federal dollar coded to New York 12th District (NY-12), and not an outlay register. The packet does not split allergy from infectious-disease projects, and it does not name labs. 248 is an action count: modifications and repeat awards add rows. Unique recipients are unpublished. It is not a clinic census, a trial-enrollment file, or a named-principal-investigator roster.

This page reports allergy and infectious-diseases research assistance USAspending tagged to this district. The headline $901,064,298.03 sits beside a district-wide obligation total of $22,043,695,120.58; the 4.1% share is arithmetic on those two packet facts, not a ranking of New York districts as winners or losers. District 90 and 98 placeholders are omitted from this harvest. Obligations are not outlays. Do not treat NY-12’s 93.855 cell as New York statewide NIH. The state hub is a parent.

Catalog line 93.855 without inventing a component pie

USAspending labels CFDA 93.855 as Allergy And Infectious Diseases Research. That catalog number produced $901,064,298.03 when crossed with New York 12th District (NY-12) place of performance. The program hub does not require NY-12 geography. The district hub does not require Allergy research. Only this tie applies both filters, which is why it cites 248 awards. The packet does not split allergy from infectious-disease projects, and it does not name labs.

Correlation is not causation: New York 12th District (NY-12) did not cause $901,064,298.03 by existing as a large or small place, and research employment figures are not packet facts. The join is 93.855 × NY-12 only. It is not a clinic census, a trial-enrollment file, or a named-principal-investigator roster. Do not invent contractors or award recipients to fill the gap. Campaign donations on FEC tables do not fund this USAspending cell; the datasets are separate.

How New York geography is coded on this join

New York 12th District (NY-12) on this join is a USAspending geography field, not a claim that every dollar was disbursed to residents of that district. Awards can list NY-12 while later work occurs elsewhere. Awards tagged to other New York districts belong on those ties even when the CFDA is also 93.855. New York 12th District (NY-12) is a numbered congressional place-of-performance code inside New York. Other New York districts are separate joins even when they reuse CFDA 93.855. New York 12th District (NY-12) is a numbered geography. New York 25th SMI and New York 22nd highway pairs are other CFDA joins.

New York federal spending shows how CFDA 93.855 sits beside other programs in the same state extract. $901,064,298.03 is one district-program column, not the state table. This packet does not split New York 12th District (NY-12) by county, city, or census tract. Awards that carry a different CFDA stay on those other ties even if the work sounds related to Allergy And Infectious Diseases Research. The district-wide obligation total published here is $22,043,695,120.58; $901,064,298.03 is the Allergy research slice of that denominator.

What the dollar figure is allowed to mean

USAspending.gov records an obligation when the federal government commits funds on an award. $901,064,298.03 is that kind of sum for Allergy And Infectious Diseases Research inside NY-12 coding. Later deobligations, recoveries, or payment schedules can change what leaves the Treasury without this join rewriting itself into a cash register. This packet does not split assistance from contracts. Net obligations can include downward adjustments. This page reports $901,064,298.03 as given. Treating $901,064,298.03 as trials already completed confuses obligation with outlay.

New York’s own budget is a separate ledger. Mixing it with the 248-row Allergy research cell leaves USAspending.gov. Treat 248 as award records in the aggregate, not unique vendors and not labs, trials, or investigators. Do not annualize without a year field in the packet. Do not per-capita or per-recipient the dollar total; those denominators are unpublished. The implied mean ($3,633,323.78) is a concentration statistic, not a published cost per grant and not a typical R01. Do not treat NY-12’s 93.855 cell as New York statewide NIH. The state hub is a parent.

Parents of this tie: district, program, state

Cite USAspending.gov: Allergy And Infectious Diseases Research (CFDA 93.855) obligated $901,064,298.03 on 248 awards coded to New York 12th District (NY-12). Name Allergy And Infectious Diseases Research and New York 12th District (NY-12) together. Keep the obligation word. If New York 12th District or CFDA 93.855 has refreshed, prefer the live hub over this snapshot for current rows. The pair is not a clinic census, a trial-enrollment file, or a named-principal-investigator roster. 4.1% of $22,043,695,120.58 is the district share on this packet, not a performance score. An nih reporter extract is a different series unless it uses CFDA 93.855, NY-12 geography, and the obligation metric.

Keep Allergy And Infectious Diseases Research, New York 12th District (NY-12), $901,064,298.03, and 248 awards together. All spending ties indexes other pairs. CFDA 93.855 is the 93.855 parent without a NY-12 filter. New York federal spending is the New York parent. Do not add those parents to this cell. Sharing a district with Allergy research does not mean campaign donations funded these awards, and it does not convert obligations into outlays. This page reports one USAspending join. The extract omits labs, trial titles, or investigator names.

Limits of the NY-12 × 93.855 snapshot

248 awards is a moderate research file. Unique investigators are unpublished. Georgia 5th’s 227-row pair is a different stamp. A large row count makes a program split tempting; the packet still does not supply one. A small row count makes a named-recipient story tempting; the packet still does not name labs, trial titles, or investigator names. The implied mean (about $3,633,323.78) and the district share (4.1% of $22,043,695,120.58) are ratios of packet facts. Prefer New York 12th District and CFDA 93.855 if the live tables moved.

Questions

How much Allergy research spending is coded to New York 12th District (NY-12)?

USAspending.gov lists $901,064,298.03 in Allergy And Infectious Diseases Research obligations across 248 awards with place of performance in New York 12th District (NY-12). CFDA 93.855 × NY-12 is an obligation join, not an outlay and not New York’s complete federal ledger. The cell is 4.1% of the district’s published total ($22,043,695,120.58). Unique recipients are unpublished. Average obligation is about $3,633,323.78, a ratio of those two facts only.

Do 248 awards mean 248 labs, trials, or investigators in NY-12?

No. Award count is a row count of USAspending actions and can include continuations and modifications. It is not a count of labs, trials, or investigators. The packet does not name recipients. See New York 12th District for named lines as USAspending stored them. The packet does not split allergy from infectious-disease projects, and it does not name labs.

Is $901,064,298.03 cash already paid in New York 12th District (NY-12)?

No. Obligations are commitments recorded on USAspending.gov awards. Outlays — money that actually left the Treasury — are a different concept and are not this packet’s headline. Treating $901,064,298.03 as trials already completed confuses those terms. Later ingests can revise 248 awards. Prefer the live district and program hubs if the tables moved.

Do FEC donations fund these Allergy research awards in NY-12?

No. FEC receipts and USAspending obligations are different datasets. Sharing New York geography does not mean donations funded $901,064,298.03 in New York 12th District (NY-12). This page reports USAspending.gov CFDA 93.855 crossed with place of performance NY-12. It does not report campaign finance.